Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty

Woo Young Chung, Mi Jung Han, Young Seok Cho, Kwang Il Kim, Hyuk Jai Chang, Tae Jin Youn, In Ho Chae, Dong Ju Choi, Cheol Ho Kim, Byung Hee Oh, Young Bae Park, Yun Shik Choi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The effect of adjunctive heparin for primary angioplasty in patients with ST-elevation myocardial infarction (STEMI) is not well established, so the authors investigated the effect of early heparin administration in the emergency room (ER) on initial patency of the infarct-related artery (IRA) and on the clinical outcome in STEMI patients. Methods and Results: One hundred and twenty consecutive patients who presented with STEMI less than 12 h from pain onset and who were eligible for primary percutaneous coronary intervention were allocated to an early heparin group (heparin administered in ER) or a late heparin group (heparin administered after angiography). In the early heparin group, unfractionated heparin (60 U/kg bolus IV, then 14U·kg-1·h-1 IV infusion) or enoxaparin (1 mg/kg bolus SC) were administered 144±95 min before angioplasty. No significant differences in baseline characteristics were observed between the early heparin group (n=56) and the late heparin group (n=64). However, initial Thrombolysis In Myocardial Infarction (TIMI) flow grade in the IRA was significantly different between the 2 groups (frequency of TIMI 0/1/2/3; 48/4/7/41% vs 70/8/11/11%, early vs late respectively, p=0.002). TIMI 2 or 3 flow was significantly more frequent in the early heparin group than in the late heparin group (48% vs 22%, p=0.002). However, no significant differences were noted between the 2 groups in terms of in-hospital major adverse cardiac events (7% vs 11%, p=0.472) and TIMI major bleeding (2% vs 3%, p=0.639). Conclusions: In STEMI patients, early heparin therapy administered in the ER improves coronary patency, despite not reaching clinical benefit.

Original languageEnglish
Pages (from-to)862-867
Number of pages6
JournalCirculation Journal
Volume71
Issue number6
DOIs
Publication statusPublished - 2007 Jun 4

Fingerprint

Angioplasty
Heparin
Myocardial Infarction
Hospital Emergency Service
ST Elevation Myocardial Infarction
Arteries
Enoxaparin
Percutaneous Coronary Intervention
Secondary Prevention
Angiography
Hemorrhage
Pain

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Chung, Woo Young ; Han, Mi Jung ; Cho, Young Seok ; Kim, Kwang Il ; Chang, Hyuk Jai ; Youn, Tae Jin ; Chae, In Ho ; Choi, Dong Ju ; Kim, Cheol Ho ; Oh, Byung Hee ; Park, Young Bae ; Choi, Yun Shik. / Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty. In: Circulation Journal. 2007 ; Vol. 71, No. 6. pp. 862-867.
@article{6275c22d342d41a4be434404471619a3,
title = "Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty",
abstract = "Background: The effect of adjunctive heparin for primary angioplasty in patients with ST-elevation myocardial infarction (STEMI) is not well established, so the authors investigated the effect of early heparin administration in the emergency room (ER) on initial patency of the infarct-related artery (IRA) and on the clinical outcome in STEMI patients. Methods and Results: One hundred and twenty consecutive patients who presented with STEMI less than 12 h from pain onset and who were eligible for primary percutaneous coronary intervention were allocated to an early heparin group (heparin administered in ER) or a late heparin group (heparin administered after angiography). In the early heparin group, unfractionated heparin (60 U/kg bolus IV, then 14U·kg-1·h-1 IV infusion) or enoxaparin (1 mg/kg bolus SC) were administered 144±95 min before angioplasty. No significant differences in baseline characteristics were observed between the early heparin group (n=56) and the late heparin group (n=64). However, initial Thrombolysis In Myocardial Infarction (TIMI) flow grade in the IRA was significantly different between the 2 groups (frequency of TIMI 0/1/2/3; 48/4/7/41{\%} vs 70/8/11/11{\%}, early vs late respectively, p=0.002). TIMI 2 or 3 flow was significantly more frequent in the early heparin group than in the late heparin group (48{\%} vs 22{\%}, p=0.002). However, no significant differences were noted between the 2 groups in terms of in-hospital major adverse cardiac events (7{\%} vs 11{\%}, p=0.472) and TIMI major bleeding (2{\%} vs 3{\%}, p=0.639). Conclusions: In STEMI patients, early heparin therapy administered in the ER improves coronary patency, despite not reaching clinical benefit.",
author = "Chung, {Woo Young} and Han, {Mi Jung} and Cho, {Young Seok} and Kim, {Kwang Il} and Chang, {Hyuk Jai} and Youn, {Tae Jin} and Chae, {In Ho} and Choi, {Dong Ju} and Kim, {Cheol Ho} and Oh, {Byung Hee} and Park, {Young Bae} and Choi, {Yun Shik}",
year = "2007",
month = "6",
day = "4",
doi = "10.1253/circj.71.862",
language = "English",
volume = "71",
pages = "862--867",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "6",

}

Chung, WY, Han, MJ, Cho, YS, Kim, KI, Chang, HJ, Youn, TJ, Chae, IH, Choi, DJ, Kim, CH, Oh, BH, Park, YB & Choi, YS 2007, 'Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty', Circulation Journal, vol. 71, no. 6, pp. 862-867. https://doi.org/10.1253/circj.71.862

Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty. / Chung, Woo Young; Han, Mi Jung; Cho, Young Seok; Kim, Kwang Il; Chang, Hyuk Jai; Youn, Tae Jin; Chae, In Ho; Choi, Dong Ju; Kim, Cheol Ho; Oh, Byung Hee; Park, Young Bae; Choi, Yun Shik.

In: Circulation Journal, Vol. 71, No. 6, 04.06.2007, p. 862-867.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty

AU - Chung, Woo Young

AU - Han, Mi Jung

AU - Cho, Young Seok

AU - Kim, Kwang Il

AU - Chang, Hyuk Jai

AU - Youn, Tae Jin

AU - Chae, In Ho

AU - Choi, Dong Ju

AU - Kim, Cheol Ho

AU - Oh, Byung Hee

AU - Park, Young Bae

AU - Choi, Yun Shik

PY - 2007/6/4

Y1 - 2007/6/4

N2 - Background: The effect of adjunctive heparin for primary angioplasty in patients with ST-elevation myocardial infarction (STEMI) is not well established, so the authors investigated the effect of early heparin administration in the emergency room (ER) on initial patency of the infarct-related artery (IRA) and on the clinical outcome in STEMI patients. Methods and Results: One hundred and twenty consecutive patients who presented with STEMI less than 12 h from pain onset and who were eligible for primary percutaneous coronary intervention were allocated to an early heparin group (heparin administered in ER) or a late heparin group (heparin administered after angiography). In the early heparin group, unfractionated heparin (60 U/kg bolus IV, then 14U·kg-1·h-1 IV infusion) or enoxaparin (1 mg/kg bolus SC) were administered 144±95 min before angioplasty. No significant differences in baseline characteristics were observed between the early heparin group (n=56) and the late heparin group (n=64). However, initial Thrombolysis In Myocardial Infarction (TIMI) flow grade in the IRA was significantly different between the 2 groups (frequency of TIMI 0/1/2/3; 48/4/7/41% vs 70/8/11/11%, early vs late respectively, p=0.002). TIMI 2 or 3 flow was significantly more frequent in the early heparin group than in the late heparin group (48% vs 22%, p=0.002). However, no significant differences were noted between the 2 groups in terms of in-hospital major adverse cardiac events (7% vs 11%, p=0.472) and TIMI major bleeding (2% vs 3%, p=0.639). Conclusions: In STEMI patients, early heparin therapy administered in the ER improves coronary patency, despite not reaching clinical benefit.

AB - Background: The effect of adjunctive heparin for primary angioplasty in patients with ST-elevation myocardial infarction (STEMI) is not well established, so the authors investigated the effect of early heparin administration in the emergency room (ER) on initial patency of the infarct-related artery (IRA) and on the clinical outcome in STEMI patients. Methods and Results: One hundred and twenty consecutive patients who presented with STEMI less than 12 h from pain onset and who were eligible for primary percutaneous coronary intervention were allocated to an early heparin group (heparin administered in ER) or a late heparin group (heparin administered after angiography). In the early heparin group, unfractionated heparin (60 U/kg bolus IV, then 14U·kg-1·h-1 IV infusion) or enoxaparin (1 mg/kg bolus SC) were administered 144±95 min before angioplasty. No significant differences in baseline characteristics were observed between the early heparin group (n=56) and the late heparin group (n=64). However, initial Thrombolysis In Myocardial Infarction (TIMI) flow grade in the IRA was significantly different between the 2 groups (frequency of TIMI 0/1/2/3; 48/4/7/41% vs 70/8/11/11%, early vs late respectively, p=0.002). TIMI 2 or 3 flow was significantly more frequent in the early heparin group than in the late heparin group (48% vs 22%, p=0.002). However, no significant differences were noted between the 2 groups in terms of in-hospital major adverse cardiac events (7% vs 11%, p=0.472) and TIMI major bleeding (2% vs 3%, p=0.639). Conclusions: In STEMI patients, early heparin therapy administered in the ER improves coronary patency, despite not reaching clinical benefit.

UR - http://www.scopus.com/inward/record.url?scp=34249725091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249725091&partnerID=8YFLogxK

U2 - 10.1253/circj.71.862

DO - 10.1253/circj.71.862

M3 - Article

C2 - 17526981

AN - SCOPUS:34249725091

VL - 71

SP - 862

EP - 867

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 6

ER -